Clinical Trials Directory

Trials / Completed

CompletedNCT00158925

The EASYTRAK EPI Clinical Investigation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Boston Scientific Corporation · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess the safety and effectiveness of the EASYTRAK EPI lead.

Detailed description

This is a prospective, single-armed, multi-center U.S., Australian, Canadian, and European clinical investigation, designed to demonstrate the safety and effectiveness of the EASYTRAK EPI lead in humans.

Conditions

Interventions

TypeNameDescription
DEVICEEASYTRAK EPI leadEASYTRAK EPI lead

Timeline

Start date
2004-09-01
Primary completion
2008-02-01
Completion
2008-02-01
First posted
2005-09-12
Last updated
2017-05-31
Results posted
2017-04-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00158925. Inclusion in this directory is not an endorsement.